These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 603392

  • 1. [Action of calcium dobesilate on capillary fragility in diabetics].
    Beretta P, Sartori F.
    Arch Sci Med (Torino); 1977; 134(3):329-36. PubMed ID: 603392
    [Abstract] [Full Text] [Related]

  • 2. [Capillary fragility in diabetics and its modification by calcium dobesilate].
    Zabel-Langhennig R, Kulle M.
    Z Gesamte Inn Med; 1983 Dec 01; 38(23):633-6. PubMed ID: 6670338
    [Abstract] [Full Text] [Related]

  • 3. What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
    Cuendet JF, Sevin R.
    Bull Ophthalmol Soc Egypt; 1976 Dec 01; 69(73):469-74. PubMed ID: 1031108
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutical action of Doxium (calcium-dobesilate) in diabetic retinopathy].
    Zygulska-Machowa H, Maciejewski Z, Szopińska-Cibowa L, Pasadyn J, Bryk E.
    Klin Oczna; 1976 Jun 01; 46(6):633-8. PubMed ID: 966623
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
    Salama Benarroch I, Nano H, Pérez H, Elizalde F, Bisceglia H, Salama A.
    Ophthalmologica; 1977 Jun 01; 174(1):47-51. PubMed ID: 322009
    [Abstract] [Full Text] [Related]

  • 6. [Results of the use of calcium dobesilate in diabetic retinopathy].
    Trutneva KV, Katsnel'son LA, Dudnikova LK, Balishanskaia TI.
    Vestn Oftalmol; 1978 Jun 01; (2):68-71. PubMed ID: 653927
    [No Abstract] [Full Text] [Related]

  • 7. [Calcium dobesilate].
    Reuter H.
    Z Allgemeinmed; 1975 Feb 28; 51(6):292-3. PubMed ID: 1092080
    [No Abstract] [Full Text] [Related]

  • 8. [Protection by cinnarizine-calcium dobesilate of cerebral lesions induced by histamine in rats].
    Scordo D, Grana D, Beigelman R, Storino R, Milei J.
    Medicina (B Aires); 1988 Feb 28; 48(3):260-4. PubMed ID: 3246961
    [No Abstract] [Full Text] [Related]

  • 9. [Calcium dobesilate, hemorheology, fibrinolysis and endothelium. New perspectives on the prevention of diabetic microangiopathy. Clinical pharmacological study].
    Guerrini M, Pieragalli D, Acciavatti A, Galigani C, Guideri F, Franchi M, Landini F, Burresi A, Messa GL, Frigerio C.
    Clin Ter; 1989 May 31; 129(4):271-85. PubMed ID: 2527121
    [Abstract] [Full Text] [Related]

  • 10. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL, Smith ME, Aronson SB, Cavender JC, Cleasby GW, Fung WE, Becker B.
    Ophthalmology; 1978 Jun 31; 85(6):594-606. PubMed ID: 353623
    [Abstract] [Full Text] [Related]

  • 11. A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy.
    Daubresse JC, Meunier R, Dumont P.
    Diabete Metab; 1977 Mar 31; 3(1):27-30. PubMed ID: 323086
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence iris angiography in the assessment of calcium dobesilate therapy in the treatment of diabetic microangiopathy.
    Grignolo FM, Musso M, Borromeo P, Sebastiani F.
    Ophthalmologica; 1979 Mar 31; 178(5):250-8. PubMed ID: 91149
    [Abstract] [Full Text] [Related]

  • 13. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP, Michal M.
    Vasa; 1986 Mar 31; 15(3):200-5. PubMed ID: 3532608
    [No Abstract] [Full Text] [Related]

  • 14. [Long term treatment of diabetic retinopathy with doxium].
    Sévin R.
    Ther Ggw; 1978 Dec 31; 117(12):1963. PubMed ID: 725811
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of the diabetic retinopathy with doxium-clofibrate (author's transl)].
    Freyler H, Egerer I.
    Klin Monbl Augenheilkd; 1976 Mar 31; 168(3):377-86. PubMed ID: 787642
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of calcium dobesilate in the treatment of cerebral circulatory insufficiency. Apropos of 30 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1974 Oct 31; 19(8 Suppl 3):886-9. PubMed ID: 4618592
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of angioprotectors on the glomerular filtration rate and vascular permeability in diabetic angiopathies].
    Tirkina TN, Mirkhodzhaev AKh, Alekseev IuP, Ionushas BS, Kasymova SD.
    Probl Endokrinol (Mosk); 1979 Oct 31; 25(4):11-6. PubMed ID: 471968
    [Abstract] [Full Text] [Related]

  • 18. [Study of the action of a vascular protector on diabetic vascular fragility].
    Nove-Josserand G, Chirat P, Bussy L, Bonnamour C, Peaud PY, Ortonne JP, Gaillarde B, Plauchu M.
    Lyon Med; 1971 Dec 12; 226(19):791-4. PubMed ID: 5159275
    [No Abstract] [Full Text] [Related]

  • 19. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
    Larsen HW, Sander E, Hoppe R.
    Diabetologia; 1977 Apr 12; 13(2):105-9. PubMed ID: 323093
    [Abstract] [Full Text] [Related]

  • 20. Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy.
    Vinazzer H, Hachen HJ.
    Vasa; 1987 Apr 12; 16(2):190-2. PubMed ID: 3300085
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.